Clinical Trial Update: Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Fermagate in combination with Sevelamer Hydrochloride for chronic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Fermagate
• Sevelamer hydrochloride (sevelamer hydrochloride)

Snippet

Sponsor: Ineos Healthcare Limited | Conditions: Chronic Kidney Failure | Phase 3 | Status: TERMINATED